About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Neurodegenerative Disease Market Size & Demand By 2030
Neurodegenerative Disease Market

Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy (SMA) , Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Acetylcholinesterase (AChE) Inhibitors, Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitor, SSRIs, Other Drug Types) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI1582DR
Last Updated : Oct 17, 2024
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Neurodegenerative Disease Market, By Indication Type (2020-2030)
    1. Parkinson's Disease
    2. Alzheimer's Disease
    3. Multiple Sclerosis
    4. Huntington Disease
    5. Amyotrophic Lateral Sclerosis
    6. Spinal Muscular Atrophy (SMA) 
    7. Other Indication Types
  2. Neurodegenerative Disease Market, By Drug Type (2020-2030)
    1. N-methyl-D-aspartate Receptor antagonists
    2. Cholinesterase Inhibitors
    3. Dopamine Agonists
    4. Immunomodulatory Drugs
    5. Acetylcholinesterase (AChE) Inhibitors
    6. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
    7. Catechol-O-Methyltransferase (COMT) Inhibitor
    8. SSRIs
    9. Other Drug Types
    1. North America
      1. North America Neurodegenerative Disease Market, By Indication Type
        1. Parkinson's Disease
          1. Alzheimer's Disease
            1. Multiple Sclerosis
              1. Huntington Disease
                1. Amyotrophic Lateral Sclerosis
                  1. Spinal Muscular Atrophy (SMA) 
                    1. Other Indication Types
                    2. North America Neurodegenerative Disease Market, By Drug Type
                      1. N-methyl-D-aspartate Receptor antagonists
                        1. Cholinesterase Inhibitors
                          1. Dopamine Agonists
                            1. Immunomodulatory Drugs
                              1. Acetylcholinesterase (AChE) Inhibitors
                                1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                  1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                    1. SSRIs
                                      1. Other Drug Types
                                      2. U.S.
                                        1. U.S. Neurodegenerative Disease Market, By Indication Type
                                          1. Parkinson's Disease
                                            1. Alzheimer's Disease
                                              1. Multiple Sclerosis
                                                1. Huntington Disease
                                                  1. Amyotrophic Lateral Sclerosis
                                                    1. Spinal Muscular Atrophy (SMA) 
                                                      1. Other Indication Types
                                                      2. U.S. Neurodegenerative Disease Market, By Drug Type
                                                        1. N-methyl-D-aspartate Receptor antagonists
                                                          1. Cholinesterase Inhibitors
                                                            1. Dopamine Agonists
                                                              1. Immunomodulatory Drugs
                                                                1. Acetylcholinesterase (AChE) Inhibitors
                                                                  1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                    1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                      1. SSRIs
                                                                        1. Other Drug Types
                                                                      2. Canada
                                                                    2. Europe
                                                                      1. Europe Neurodegenerative Disease Market, By Indication Type
                                                                        1. Parkinson's Disease
                                                                          1. Alzheimer's Disease
                                                                            1. Multiple Sclerosis
                                                                              1. Huntington Disease
                                                                                1. Amyotrophic Lateral Sclerosis
                                                                                  1. Spinal Muscular Atrophy (SMA) 
                                                                                    1. Other Indication Types
                                                                                    2. Europe Neurodegenerative Disease Market, By Drug Type
                                                                                      1. N-methyl-D-aspartate Receptor antagonists
                                                                                        1. Cholinesterase Inhibitors
                                                                                          1. Dopamine Agonists
                                                                                            1. Immunomodulatory Drugs
                                                                                              1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                  1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                    1. SSRIs
                                                                                                      1. Other Drug Types
                                                                                                      2. U.K.
                                                                                                        1. U.K. Neurodegenerative Disease Market, By Indication Type
                                                                                                          1. Parkinson's Disease
                                                                                                            1. Alzheimer's Disease
                                                                                                              1. Multiple Sclerosis
                                                                                                                1. Huntington Disease
                                                                                                                  1. Amyotrophic Lateral Sclerosis
                                                                                                                    1. Spinal Muscular Atrophy (SMA) 
                                                                                                                      1. Other Indication Types
                                                                                                                      2. U.K. Neurodegenerative Disease Market, By Drug Type
                                                                                                                        1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                          1. Cholinesterase Inhibitors
                                                                                                                            1. Dopamine Agonists
                                                                                                                              1. Immunomodulatory Drugs
                                                                                                                                1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                  1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                    1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                      1. SSRIs
                                                                                                                                        1. Other Drug Types
                                                                                                                                      2. Germany
                                                                                                                                      3. France
                                                                                                                                      4. Spain
                                                                                                                                      5. Italy
                                                                                                                                      6. Russia
                                                                                                                                      7. Nordic
                                                                                                                                      8. Benelux
                                                                                                                                      9. Rest of Europe
                                                                                                                                    2. APAC
                                                                                                                                      1. APAC Neurodegenerative Disease Market, By Indication Type
                                                                                                                                        1. Parkinson's Disease
                                                                                                                                          1. Alzheimer's Disease
                                                                                                                                            1. Multiple Sclerosis
                                                                                                                                              1. Huntington Disease
                                                                                                                                                1. Amyotrophic Lateral Sclerosis
                                                                                                                                                  1. Spinal Muscular Atrophy (SMA) 
                                                                                                                                                    1. Other Indication Types
                                                                                                                                                    2. APAC Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                      1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                                                        1. Cholinesterase Inhibitors
                                                                                                                                                          1. Dopamine Agonists
                                                                                                                                                            1. Immunomodulatory Drugs
                                                                                                                                                              1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                                                1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                                                  1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                                                    1. SSRIs
                                                                                                                                                                      1. Other Drug Types
                                                                                                                                                                      2. China
                                                                                                                                                                        1. China Neurodegenerative Disease Market, By Indication Type
                                                                                                                                                                          1. Parkinson's Disease
                                                                                                                                                                            1. Alzheimer's Disease
                                                                                                                                                                              1. Multiple Sclerosis
                                                                                                                                                                                1. Huntington Disease
                                                                                                                                                                                  1. Amyotrophic Lateral Sclerosis
                                                                                                                                                                                    1. Spinal Muscular Atrophy (SMA) 
                                                                                                                                                                                      1. Other Indication Types
                                                                                                                                                                                      2. China Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                                                        1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                                                                                          1. Cholinesterase Inhibitors
                                                                                                                                                                                            1. Dopamine Agonists
                                                                                                                                                                                              1. Immunomodulatory Drugs
                                                                                                                                                                                                1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                                                                                  1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                                                                                    1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                                                                                      1. SSRIs
                                                                                                                                                                                                        1. Other Drug Types
                                                                                                                                                                                                      2. Korea
                                                                                                                                                                                                      3. Japan
                                                                                                                                                                                                      4. India
                                                                                                                                                                                                      5. Australia
                                                                                                                                                                                                      6. Taiwan
                                                                                                                                                                                                      7. South East Asia
                                                                                                                                                                                                      8. Rest of Asia-Pacific
                                                                                                                                                                                                    2. Middle East and Africa
                                                                                                                                                                                                      1. Middle East and Africa Neurodegenerative Disease Market, By Indication Type
                                                                                                                                                                                                        1. Parkinson's Disease
                                                                                                                                                                                                          1. Alzheimer's Disease
                                                                                                                                                                                                            1. Multiple Sclerosis
                                                                                                                                                                                                              1. Huntington Disease
                                                                                                                                                                                                                1. Amyotrophic Lateral Sclerosis
                                                                                                                                                                                                                  1. Spinal Muscular Atrophy (SMA) 
                                                                                                                                                                                                                    1. Other Indication Types
                                                                                                                                                                                                                    2. Middle East and Africa Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                                                                                      1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                                                                                                                        1. Cholinesterase Inhibitors
                                                                                                                                                                                                                          1. Dopamine Agonists
                                                                                                                                                                                                                            1. Immunomodulatory Drugs
                                                                                                                                                                                                                              1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                                                                                                                1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                                                                                                                  1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                                                                                                                    1. SSRIs
                                                                                                                                                                                                                                      1. Other Drug Types
                                                                                                                                                                                                                                      2. UAE
                                                                                                                                                                                                                                        1. UAE Neurodegenerative Disease Market, By Indication Type
                                                                                                                                                                                                                                          1. Parkinson's Disease
                                                                                                                                                                                                                                            1. Alzheimer's Disease
                                                                                                                                                                                                                                              1. Multiple Sclerosis
                                                                                                                                                                                                                                                1. Huntington Disease
                                                                                                                                                                                                                                                  1. Amyotrophic Lateral Sclerosis
                                                                                                                                                                                                                                                    1. Spinal Muscular Atrophy (SMA) 
                                                                                                                                                                                                                                                      1. Other Indication Types
                                                                                                                                                                                                                                                      2. UAE Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                                                                                                                        1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                                                                                                                                                          1. Cholinesterase Inhibitors
                                                                                                                                                                                                                                                            1. Dopamine Agonists
                                                                                                                                                                                                                                                              1. Immunomodulatory Drugs
                                                                                                                                                                                                                                                                1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                                                                                                                                                  1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                                                                                                                                                    1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                                                                                                                                                      1. SSRIs
                                                                                                                                                                                                                                                                        1. Other Drug Types
                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                      1. LATAM Neurodegenerative Disease Market, By Indication Type
                                                                                                                                                                                                                                                                        1. Parkinson's Disease
                                                                                                                                                                                                                                                                          1. Alzheimer's Disease
                                                                                                                                                                                                                                                                            1. Multiple Sclerosis
                                                                                                                                                                                                                                                                              1. Huntington Disease
                                                                                                                                                                                                                                                                                1. Amyotrophic Lateral Sclerosis
                                                                                                                                                                                                                                                                                  1. Spinal Muscular Atrophy (SMA) 
                                                                                                                                                                                                                                                                                    1. Other Indication Types
                                                                                                                                                                                                                                                                                    2. LATAM Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                                                                                                                                                      1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                                                                                                                                                                                        1. Cholinesterase Inhibitors
                                                                                                                                                                                                                                                                                          1. Dopamine Agonists
                                                                                                                                                                                                                                                                                            1. Immunomodulatory Drugs
                                                                                                                                                                                                                                                                                              1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                                                                                                                                                                                1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                                                                                                                                                                                  1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                                                                                                                                                                                    1. SSRIs
                                                                                                                                                                                                                                                                                                      1. Other Drug Types
                                                                                                                                                                                                                                                                                                      2. Brazil
                                                                                                                                                                                                                                                                                                        1. Brazil Neurodegenerative Disease Market, By Indication Type
                                                                                                                                                                                                                                                                                                          1. Parkinson's Disease
                                                                                                                                                                                                                                                                                                            1. Alzheimer's Disease
                                                                                                                                                                                                                                                                                                              1. Multiple Sclerosis
                                                                                                                                                                                                                                                                                                                1. Huntington Disease
                                                                                                                                                                                                                                                                                                                  1. Amyotrophic Lateral Sclerosis
                                                                                                                                                                                                                                                                                                                    1. Spinal Muscular Atrophy (SMA) 
                                                                                                                                                                                                                                                                                                                      1. Other Indication Types
                                                                                                                                                                                                                                                                                                                      2. Brazil Neurodegenerative Disease Market, By Drug Type
                                                                                                                                                                                                                                                                                                                        1. N-methyl-D-aspartate Receptor antagonists
                                                                                                                                                                                                                                                                                                                          1. Cholinesterase Inhibitors
                                                                                                                                                                                                                                                                                                                            1. Dopamine Agonists
                                                                                                                                                                                                                                                                                                                              1. Immunomodulatory Drugs
                                                                                                                                                                                                                                                                                                                                1. Acetylcholinesterase (AChE) Inhibitors
                                                                                                                                                                                                                                                                                                                                  1. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
                                                                                                                                                                                                                                                                                                                                    1. Catechol-O-Methyltransferase (COMT) Inhibitor
                                                                                                                                                                                                                                                                                                                                      1. SSRIs
                                                                                                                                                                                                                                                                                                                                        1. Other Drug Types
                                                                                                                                                                                                                                                                                                                                      2. Mexico
                                                                                                                                                                                                                                                                                                                                      3. Argentina
                                                                                                                                                                                                                                                                                                                                      4. Chile
                                                                                                                                                                                                                                                                                                                                      5. Colombia
                                                                                                                                                                                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                  Related Reports

                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                  Regenerative Medicine Market Size The global regenerative medicine market size is estimated to be worth USD 19.80 billion in 2024 and is projected to reach from USD 24.88 billion in 2025 to USD 148.42 billion by 2033, growing at
                                                                                                                                                                                                                                                                                                                                  Buy Now

                                                                                                                                                                                                                                                                                                                                  Purchase Benefits

                                                                                                                                                                                                                                                                                                                                  • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                                                  • Completely customizable scope
                                                                                                                                                                                                                                                                                                                                  • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                                                  • Dedicated account manager
                                                                                                                                                                                                                                                                                                                                  • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                                                  • Permission to print the report

                                                                                                                                                                                                                                                                                                                                  We are featured on :

                                                                                                                                                                                                                                                                                                                                  www.straitsresearch.com
                                                                                                                                                                                                                                                                                                                                  © Copyright . All rights Reserved.